Animal models relevant to schizophrenia and autism: validity and limitations.
about
Exploring the Validity of Valproic Acid Animal Model of AutismUnderstanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patientsEffects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical updateChanges in plasticity across the lifespan: cause of disease and target for interventionUse of transcranial magnetic stimulation in autism spectrum disordersRelationships among parvalbumin-immunoreactive neuron density, phase-locked gamma oscillations, and autistic/schizophrenic symptoms in PDGFR-β knock-out and control miceEpilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in ratsMaternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates.Characterization of the deleted in autism 1 protein family: implications for studying cognitive disorders.Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autismAre NCAM deficient mice an animal model for schizophrenia?Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk.Evaluation of animal models of neurobehavioral disorders.Methamphetamine-induced deficits in social interaction are not observed following abstinence from single or repeated exposures.Chronic metals ingestion by prairie voles produces sex-specific deficits in social behavior: an animal model of autism.Promise and pitfalls of animal models of schizophreniaGene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms.Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.Characterization of neonatal vocal and motor repertoire of reelin mutant miceGene expression profiling in rodent models for schizophrenia.Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report.Identification of the novel localization of tenascinX in the monkey choroid plexus and comparison with the mouseAdvances in reprogramming-based study of neurologic disordersBrain-derived neurotrophic factor and neuropsychiatric disorders.Abnormal modulation of corticospinal excitability in adults with Asperger's syndrome.Altered anxiety-related and abnormal social behaviors in rats exposed to early life seizures.Animal models of autism: an epigenetic and environmental viewpoint.The utility of behavioral economics in expanding the free-feed model of obesity.The Current Status of the Ketogenic Diet in Psychiatry.Challenges in drug target discovery in bipolar disorder.Novel routes to bipolar disorder drug discovery.Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.Using iPSCs and genomics to catch CNVs in the act.Abnormal Mechanisms of Plasticity and Metaplasticity in Autism Spectrum Disorders and Fragile X Syndrome.Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.From molecules to behavior: lessons from the study of rare genetic disorders.Teaching neurophysiology, neuropharmacology, and experimental design using animal models of psychiatric and neurological disorders.Distinct Phenotypes of Mouse Models Reflect Neuropsychiatric Spectrum Disorders of Human Patients With Variants
P2860
Q26771764-E61C978E-0EEC-4B3F-B99A-AEFC63B52D80Q26784399-1917EEC8-0EF9-4541-9E5A-41C657F17E27Q26823735-D887A421-617A-4FE2-87DE-AED0F9F036C8Q27022671-D2A1597C-3885-420F-A30C-64D431A852A2Q28300252-C68DB6A7-24F0-4BBC-BCB3-53E2A6AC9834Q28544934-913EB4B5-C6C3-4BD2-A002-EE8633CC9896Q28584071-CFE4B576-C5C0-4B86-B06B-5BDB5F4FEF68Q30238718-2827CEDF-17A3-4F52-8199-663BD6A65FC6Q30399182-FF4CF89A-19D8-473E-9A45-BE16C6467BFEQ30454923-ED8360A1-5F55-449F-98D2-46D49ABD9B04Q30465582-C2C2513B-9724-4BD4-B808-7F05C9A94D6CQ30485438-A78CB0C8-7F17-45CD-92CE-39CFA5168412Q30490127-35498106-62DA-40DF-8A79-AF9E937996EEQ30672716-E71A4C38-C830-460C-9CE3-2FEC06DB26FFQ33893359-3387532D-FD35-45BB-95B6-BB05D41D3AC5Q33956579-58BA43F3-2150-42AC-A85E-B650DFCCD070Q33997473-BC26C021-418A-47F5-98E2-D0FAAB6B3789Q34214660-D1F39D2D-A2D5-4477-9288-51C31D2479E4Q34735490-E006ED52-B484-489C-89A5-725168ACFDF6Q34829319-1235CF88-8D52-4903-967A-EC148117C667Q35063886-085BB38D-BF61-4328-909C-9A903D20B766Q35197316-147D6968-9550-44F8-8E99-21D28B2A8A9EQ35635245-34A22332-563A-4227-B1B8-4B9C26EAF606Q35847085-9E8789C1-5673-4D4E-A3A6-4ED7B4F8C2DFQ36474435-AED14CF7-4261-4F1F-97C6-EEB0290A0CDDQ36828900-3BDFF8D4-43B4-4B6E-8898-226C11892977Q36866412-4D22574C-3D1B-4753-886F-DB1458268C30Q36905942-2CE9A880-32DC-4497-A7D2-1DB4C342D721Q37710385-0D6DA0BF-410F-4B71-B9A3-954E338F5DC7Q38082552-FE7973EC-5DAB-4476-8C44-F3FB56A9CEF0Q38109244-9294AA97-BC23-4E37-A062-A28185DF7FD4Q38674187-9A9C6ADF-F936-4D70-8813-8BCC901A06F2Q38775856-33425524-7089-416E-B02F-74AC5C2F12E0Q40252888-F33D55B5-E723-4DDD-8629-0A432CB0719CQ42071146-D6446070-C1BB-4DD6-A712-A6DDB64A9353Q46326120-24B44277-3B74-4AA2-B66F-265EECDF8C19Q50803643-61C16107-9A36-4562-BDA7-7E9A9F622DD6Q51871708-5ADCF809-2004-48C1-8F56-3A2486D513B8Q57175338-0AD6C2CB-CA58-462E-AE60-9D25BA356040
P2860
Animal models relevant to schizophrenia and autism: validity and limitations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Animal models relevant to schizophrenia and autism: validity and limitations.
@ast
Animal models relevant to schizophrenia and autism: validity and limitations.
@en
Animal models relevant to schizophrenia and autism: validity and limitations.
@nl
type
label
Animal models relevant to schizophrenia and autism: validity and limitations.
@ast
Animal models relevant to schizophrenia and autism: validity and limitations.
@en
Animal models relevant to schizophrenia and autism: validity and limitations.
@nl
prefLabel
Animal models relevant to schizophrenia and autism: validity and limitations.
@ast
Animal models relevant to schizophrenia and autism: validity and limitations.
@en
Animal models relevant to schizophrenia and autism: validity and limitations.
@nl
P2093
P2860
P1433
P1476
Animal models relevant to schizophrenia and autism: validity and limitations
@en
P2093
Bruno Millet
Claudine Laurent
David Cohen
Dominique Drapier
Pierre L Roubertoux
Rozenn Graignic
Sylvia Fortes
Sylvie Tordjman
P2860
P2888
P356
10.1007/S10519-006-9120-5
P407
P577
2006-12-12T00:00:00Z
P5875
P6179
1016691837